Evidence map›Paper›PMID 35887536›Full record

ArticleJournal of personalized medicine2022

Experience with Photodynamic Therapy Using Indocyanine Green Liposomes for Refractory Cancer.

Kensho Yorozu, Masaki Kaibori, Shintarou Kimura, Misa Ichikawa, Kosuke Matsui, Soichiro Kaneshige, Masanori Kobayashi, Daiki Jimbo, Yusuke Torikai, Yoshitaka Fukuzawa and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Kensho YorozuYorozu Clinic, 1-118-4 Mihagino, Tottori 689-0202, Japan.ORCID 0000-0003-1194-9855
Masaki KaiboriDepartment of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka 573-1191, Japan.ORCID 0000-0002-0577-3921
Shintarou KimuraStateArt Inc., StateArt Bild 2-9-12 Nihonbashi Horidomecho, Chuo-ku, Tokyo 103-0012, Japan.
Misa IchikawaStateArt Inc., StateArt Bild 2-9-12 Nihonbashi Horidomecho, Chuo-ku, Tokyo 103-0012, Japan.
Kosuke MatsuiDepartment of Surgery, Kansai Medical University, 2-5-1 Shinmachi, Hirakata, Osaka 573-1191, Japan.
Soichiro KaneshigeDepartment of Radiation Oncology, Okayama Central Hospital, 6-3 Ishimakitamachi, Okayama 700-0017, Japan.
Masanori KobayashiSerenclinic-Nagoya, 2F, Hisaya Park Bld, 4-14-2 Sakae, Naka-ku, Nagoya, Aichi 460-0008, Japan.
Daiki JimboAichi Medical University Hospital Preemptive & Integrative Medicine Center 1-1, Iwasaku Karimata, Nagakute, Aichi 480-1195, Japan.
Yusuke TorikaiYorozu Clinic, 1-118-4 Mihagino, Tottori 689-0202, Japan.
Yoshitaka FukuzawaAichi Medical University Hospital Preemptive & Integrative Medicine Center 1-1, Iwasaku Karimata, Nagakute, Aichi 480-1195, Japan.
Yoshiharu OkamotoDepartment of Veterinary Clinical Medicine, School of Veterinary Medicine, Tottori University, Tottori 680-8553, Japan.
Aichi Medical University Hospital · JPKansai Medical University · JPOkayama Central Hospital · JPTottori University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reported the development of an effective cancer treatment using a multidisciplinary treatment, including photodynamic therapy (PDT) with indocyanine green (ICG) liposomes and a combination of Lentinula edodes mycelia (LEM) and hydrogen gas inhalation therapy. ICG liposomes were prepared by adding 5 mg of ICG to 50 mL liposomes. Later, 25 mL of ICG liposomes were diluted with 250 mL of 5% glucose solution and administered intravenously to the patient. We selected the multi-laser delivery system (MLDS), a laser irradiator for performing PDT. Further, the patients received a combination of LEM and hydrogen gas inhalation therapy throughout the treatment. We reported two cases of PDT therapy, one with middle intrathoracic esophagus carcinoma and the other with hypopharyngeal cancer. In the first case, the MLDS laser was directly attached to the endoscope and directed to the cancer area with wavelengths of 810 nm. After the treatment, a biopsy demonstrated no tumor recurrence. In the second case, the patient was treated with endovascular PDT using ICG liposomes and MLDS fiber optics. Later, tumor shrinkage was demonstrated after the first round and disappeared after six months. In conclusion, the present findings suggest that the effect of PDT using ICG liposomes with LEM and hydrogen gas may eradicate cancer without burdening patients by enhancing tumor immunity.

Indexed as

esophagus carcinomahydrogen gashypopharyngeal cancerindocyanine green liposomesLentinula edodes myceliamulti-laser delivery systemphotodynamic therapy

Identifiers

PMID35887536
PMCPMC9318386
OpenAlexW4283512113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.